IndiaMTF — home
Stock

MANKIND

Mankind Pharma Limited
Health Technology

Daily Margin Trading Facility book for MANKIND across NSE and BSE, from 01 Jan 2025. All figures in ₹ crore, derived from exchange public disclosures.

Funded value
₹100 Cr
as of 10 Sep 2026
Rank in book
#380
380 days tracked
Share of book
0.07%
of the whole NSE + BSE book
Peak funded
₹103 Cr
on 16 Dec 2025
Largest single-day addition
+₹28 Cr
on 10 Jul 2026
Largest single-day unwind
−₹20 Cr
on 15 Jul 2026

NSE & BSE split

How MANKIND’s funded book divides across the two exchanges, as of 10 Sep 2026.
NSE
NSE ₹97 Cr · 96.3%BSE ₹4 Cr · 3.7%

MTF vs Price

Margin-funded outstanding for MANKIND in ₹ crore against the closing price, adjusted for splits and bonuses. Each window uses the same reference date as the table below, so the two agree. Funded value moves with the price on its own, so the line under the chart reads the share count instead — that is what shows whether more stock is genuinely being borrowed against.
MTF book (₹ Cr)

Price and liquidity

Adjusted for splits and bonuses, so a change across a corporate action reflects the market rather than the share count.
Last close
₹2,280.00
as of 11 Sep 2026
Price, 30 days
−7.7%
adjusted for splits and bonuses
Delivery, 20-day avg
58.6%
of traded volume actually settled
Sessions to unwind
2.1
of average deliverable volume
Shares under margin divided by average daily deliverable volume over the last 20 sessions.

Book, shares and price by window

Funded value moves with the price on its own, so the share count is what shows whether more stock is actually being borrowed against. The last column reads the two together.
WindowBook ΔBook %SharesPriceReading
1 day+₹0+0.1%+0.2%
+669
−1.2%building as it falls
10 days+₹11+12.8%+14.2%
+50,680
−7.4%building as it falls
30 days+₹46+86.3%+93.3%
+1,97,402
−13.1%building as it falls
90 days+₹48+92.0%+91.7%
+1,95,576
−6.0%building as it falls
180 days+₹42+70.5%+64.6%
+1,60,546
+3.5%building into strength
1 year+₹60+146.7%+142.8%
+2,40,451
−7.9%building as it falls
Price is as of 11 Sep 2026; the MTF book is as of 10 Sep 2026. Exchanges publish the margin file a day after the market data, and the comparison above uses the MTF date for both sides.

Shares under margin

Number of shares funded via MTF over time (NSE + BSE combined).

Rank trajectory

Where MANKIND has sat in the funded-value ranking each day (1 = most funded). Lower is more prominent.

MANKIND — last 30 trading days

Combined NSE + BSE funded value, day-on-day change, share of the whole book, and rank. Newest first.
DateCombined (₹ Cr)Day Δ (₹ Cr)% of bookRank
10 Sep 2026100+₹00.07%380
09 Sep 2026100+₹20.07%378
08 Sep 202698+₹20.06%388
07 Sep 202696+₹10.06%396
04 Sep 202696+₹40.06%396
03 Sep 202692+₹10.06%408
02 Sep 202691−₹10.06%412
01 Sep 202692+₹20.06%409
31 Aug 202690+₹10.06%411
28 Aug 202689+₹00.06%416
27 Aug 202689−₹10.06%410
26 Aug 202690−₹20.06%411
25 Aug 202692+₹10.06%400
24 Aug 202691+₹10.06%403
21 Aug 202690−₹00.06%406
20 Aug 202691+₹10.06%399
19 Aug 202690+₹50.06%401
18 Aug 202685−₹20.06%417
17 Aug 202687+₹30.06%412
14 Aug 202684+₹10.06%426
13 Aug 202682+₹30.06%433
12 Aug 202680+₹10.05%454
11 Aug 202678+₹10.05%458
10 Aug 202677+₹10.05%463
07 Aug 202676−₹20.05%461
06 Aug 202678+₹20.05%450
05 Aug 202676+₹10.05%458
04 Aug 202675+₹40.05%460
03 Aug 202671−₹10.05%476
31 Jul 202672—0.05%471

MANKIND within Health Technology

Ranked #19 of 61 funded Health Technology stocks, carrying 1.6% of that sector’s margin book. Nearest names by funded value:
#StockMTF book (₹ Cr)% of sector
17PPLPHARMA
Piramal Pharma Limited
₹1131.8%
18LENSKART
Lenskart Solutions Limited
₹1011.6%
19MANKIND
Mankind Pharma Limited
₹1001.6%
20ACUTAAS
Acutaas Chemicals Limited
₹1001.6%
21CIPLA
Cipla Limited
₹981.5%

All Health Technology stocks and how the sector has moved →

Disclaimer. Data sourced from daily margin trading disclosure provided by NSE and BSE. This website and page are meant for educational and information only — not investment advice. MTF is leveraged and can amplify losses. Rules, margins, rates and eligible-stock lists change; verify current details with your broker and SEBI/exchange circulars. IndiaMTF.com is not a SEBI-registered intermediary, broker, or investment adviser and has no affiliation with SEBI, NSE or BSE. Figures are reproduced from publicly disclosed exchange data, may be delayed or revised, and should be independently verified before any trading decision. Consult a SEBI-registered investment adviser before investing.